Pan, Lili
Chen, Yiqiao
Weng, Kaizhi
Guo, Biyun
Zhuang, Shuquan
Huang, Shuxian
Lian, Zhulan
Wang, Xiaofang
Li, Nainong
Zheng, Yongzhi
Funding for this research was provided by:
Startup Fund for Scientific Research, Fujian Medical University (2021QH1049)
National Key Clinical Specialty Discipline Construction Program of China (2021–76)
Fujian Provincial Clinical Research Center for Hematological Malignancies (2020Y2006)
Joint Funds for the Innovation of Science and Technology, Fujian Province (2020Y9052)
Article History
Received: 20 June 2024
Accepted: 20 August 2024
First Online: 29 August 2024
Declarations
:
: The protocol received approval from the Ethics Committee of Fujian Medical University Union Hospital. Parents or legal guardians of patients provided informed consent prior to enrolling in the study, following the principles outlined in the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.